BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 20, 2010
View Archived Issues
More Complex Disease, but a Shorter 'Translatability' Road
Read More
Design Controls May Be en Route for Lab-Developed Tests
Read More
Much-Anticipated 'Btripla' Data all the Talk at 2010 IAS Meeting
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
Ramius Seeks Hostile Buyout of Cypress Bioscience at $4/Share
Activist shareholder Ramius Value and Opportunity Advisors LLC said that it is seeking to take over Cypress Bioscience Inc., offering to buy the rest of the company shares that it does not already own for $4 per share. (BioWorld Today)
Read More
Is Venture Riding the Summer Roller Coaster?
Read More